Sponsor: ADC Therapeutics

Protocol ADCT-402-201 is a trial evaluating the efficacy and safety of Loncastuximab Tesirine in patients with diffuse large b-cell lymphoma that have previously been treated with at least two multi-agent treatment regimens.